Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trial

Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trial

Background Acute intracerebral haemorrhage (ICH) is devastating with a 1 month mortality rate of ~40%. Cerebral oedema can complicate acute ICH and is associated with poor outcome. In patients with large ICH, the accompanying swelling increases mass effect and causes brain herniation. Mannitol, an o...

Full description

Saved in:
Bibliographic Details
Main Authors: Jesse Dawson, David J Werring, Nikola Sprigg, Christine Roffe, Zhe Kang Law, Kailash Krishnan, Philip Bath, Rob A Dineen, Diane Havard, Timothy J England, Mary Joan Macleod, Stefan Pszczolkowski, Jennifer Craig, Amanda Buck, David W Hewson, Lisa Woodhouse, Fergus Doubal, Emma Grace, Keenan Wells
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/7/e103776.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/7/e103776.full

Similar Items